1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Autoinjector Market – Introduction
4.1 What is an Autoinjector?
4.2 What are the Major Types of Autoinjector
4.2.1 Disposable Autoinjector
4.2.2 Reusable Autoinjector
4.3 What are the Major Applications of Autoinjector
4.3.1 Rheumatoid Arthritis
4.3.2 Anaphylaxis
4.4 Industry Trends
4.5 Competitive Intelligence
5 Global Autoinjector Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Autoinjector Market - Breakup by Type
6.1 Disposable Autoinjector
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Forecast (2024-2032)
6.1.4 Market Breakup by Application
6.1.5 Market Breakup by End User
6.2 Reusable Autoinjector
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Forecast (2024-2032)
6.2.4 Market Breakup by Application
6.2.5 Market Breakup by End User
6.3 Attractive Investment Proposition by Type
7 Global Autoinjector Market - Breakup by Application
7.1 Rheumatoid Arthritis
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Forecast (2024-2032)
7.1.4 Market Breakup by Type
7.1.5 Market Breakup by End User
7.2 Anaphylaxis
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Forecast (2024-2032)
7.2.4 Market Breakup by Type
7.2.5 Market Breakup by End User
7.3 Multiple Sclerosis
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Forecast (2024-2032)
7.3.4 Market Breakup by Type
7.3.5 Market Breakup by End User
7.4 Others
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Forecast (2024-2032)
7.5 Attractive Investment Proposition by Application
8 Global Autoinjector Market - Breakup by End User
8.1 Homecare Settings
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Forecast (2024-2032)
8.1.4 Market Breakup by Type
8.1.5 Market Breakup by Application
8.2 Hospitals & Clinics
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Forecast (2024-2032)
8.2.4 Market Breakup by Type
8.2.5 Market Breakup by Application
8.3 Attractive Investment Proposition by End User
9 Global Autoinjector Market – Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2018-2023)
9.1.1.3 Market Breakup by Type
9.1.1.4 Market Breakup by Application
9.1.1.5 Market Breakup by End User
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2024-2032)
9.1.1.8 Government Regulations
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2018-2023)
9.1.2.3 Market Breakup by Type
9.1.2.4 Market Breakup by Application
9.1.2.5 Market Breakup by End User
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2024-2032)
9.1.2.8 Government Regulations
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2018-2023)
9.2.1.3 Market Breakup by Type
9.2.1.4 Market Breakup by Application
9.2.1.5 Market Breakup by End User
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2024-2032)
9.2.1.8 Government Regulations
9.2.2 Japan
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2018-2023)
9.2.2.3 Market Breakup by Type
9.2.2.4 Market Breakup by Application
9.2.2.5 Market Breakup by End User
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2024-2032)
9.2.2.8 Government Regulations
9.2.3 India
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2018-2023)
9.2.3.3 Market Breakup by Type
9.2.3.4 Market Breakup by Application
9.2.3.5 Market Breakup by End User
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2024-2032)
9.2.3.8 Government Regulations
9.2.4 South Korea
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2018-2023)
9.2.4.3 Market Breakup by Type
9.2.4.4 Market Breakup by Application
9.2.4.5 Market Breakup by End User
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2024-2032)
9.2.4.8 Government Regulations
9.2.5 Australia
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2018-2023)
9.2.5.3 Market Breakup by Type
9.2.5.4 Market Breakup by Application
9.2.5.5 Market Breakup by End User
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2024-2032)
9.2.5.8 Government Regulations
9.2.6 Indonesia
9.2.6.1 Market Drivers
9.2.6.2 Historical and Current Market Trends (2018-2023)
9.2.6.3 Market Breakup by Type
9.2.6.4 Market Breakup by Application
9.2.6.5 Market Breakup by End User
9.2.6.6 Key Players
9.2.6.7 Market Forecast (2024-2032)
9.2.6.8 Government Regulations
9.2.7 Others
9.2.7.1 Historical and Current Market Trends (2018-2023)
9.2.7.2 Market Forecast (2024-2032)
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2018-2023)
9.3.1.3 Market Breakup by Type
9.3.1.4 Market Breakup by Application
9.3.1.5 Market Breakup by End User
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2024-2032)
9.3.1.8 Government Regulations
9.3.2 France
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2018-2023)
9.3.2.3 Market Breakup by Type
9.3.2.4 Market Breakup by Application
9.3.2.5 Market Breakup by End User
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2024-2032)
9.3.2.8 Government Regulations
9.3.3 United Kingdom
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2018-2023)
9.3.3.3 Market Breakup by Type
9.3.3.4 Market Breakup by Application
9.3.3.5 Market Breakup by End User
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2024-2032)
9.3.3.8 Government Regulations
9.3.4 Italy
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2018-2023)
9.3.4.3 Market Breakup by Type
9.3.4.4 Market Breakup by Application
9.3.4.5 Market Breakup by End User
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2024-2032)
9.3.4.8 Government Regulations
9.3.5 Spain
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2018-2023)
9.3.5.3 Market Breakup by Type
9.3.5.4 Market Breakup by Application
9.3.5.5 Market Breakup by End User
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2024-2032)
9.3.5.8 Government Regulations
9.3.6 Others
9.3.6.1 Historical and Current Market Trends (2018-2023)
9.3.6.2 Market Forecast (2024-2032)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2018-2023)
9.4.1.3 Market Breakup by Type
9.4.1.4 Market Breakup by Application
9.4.1.5 Market Breakup by End User
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2024-2032)
9.4.1.8 Government Regulations
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2018-2023)
9.4.2.3 Market Breakup by Type
9.4.2.4 Market Breakup by Application
9.4.2.5 Market Breakup by End User
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2024-2032)
9.4.2.8 Government Regulations
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2018-2023)
9.4.3.2 Market Forecast (2024-2032)
9.5 Middle East
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Breakup by Type
9.5.4 Market Breakup by Application
9.5.5 Market Breakup by End User
9.5.6 Key Players
9.5.7 Market Forecast (2024-2032)
9.5.8 Government Regulations
9.6 Africa
9.6.1 Market Drivers
9.6.2 Historical and Current Market Trends (2018-2023)
9.6.3 Market Breakup by Type
9.6.4 Market Breakup by Application
9.6.5 Market Breakup by End User
9.6.6 Key Players
9.6.7 Market Forecast (2024-2032)
9.6.8 Government Regulations
9.7 Attractive Investment Proposition by Region
10 Market Dynamics
10.1 Market Driving Factors
10.1.1 Growing Adoption of Self Administration Therapies
10.1.2 Rising Awareness of Anaphylaxis
10.1.3 Increasing Rates of Chronic Illness
10.1.4 Rising Investment in Healthcare
10.2 Market Restraining Factors
10.2.1 Availability of Substitute Drug Delivery Methods
10.2.2 Risk of Device Error or Malfunction
10.2.3 Limited Application Range
10.3 Market Opportunities
10.3.1 Growth into a New Therapeutic Area
10.3.2 Advancement in Technology
10.3.3 Expansion in Untapped Market
10.3.4 Partnership among Companies
11 Key Technological Trends & Development
11.1 Smart AutoInjector
11.2 Voice Guided Autoinjector
11.3 Needle Free Injection Technology
11.4 Automatic Needle Retraction
11.5 Stopper Sensing Technology
11.6 Miniature Epinephrine Auto-Injector
12 Government Regulations
12.1 ISO 11608 and ISO 11040
12.2 Food and Drug Administration - FDA
12.3 Article 117 of Regulation (EU) 2017/745 on Medical Devices (MDR)
12.4 Health Canada Regulation
12.5 National Institute of Health
13 Recent Industry News
13.1 Ypsomed and Novo Nordisk signed an autoinjector supply agreement.
13.2 Eisai's METOJECT® SUBCUTANEOUS INJECTION PEN (METHOTREXATE) PEN-TYPE AUTOINJECTOR Gets Approval in Japan.
13.3 FDA approves Lilly's Mounjaro to treat type 2 diabetes.
13.4 EU approved Kesimpta®, self-administered targeted B-cell treatment for adult patients with relapse multiple sclerosis, from Lilly's MounjarNovartis.
13.5 SHL Acquired Superior Tooling Inc, US based Plastic Injection Molds manufacturer to Strengthen Vertical Capabilities
13.6 Teva Announced Approval of a Generic Version of Forteo® (teriparatide injection), in the United States
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Value Chain Analysis
16 Global Autoinjector Market – Competitive Landscape
16.1 Overview
16.2 Market Structure
16.3 Market Share by Key Players
16.4 Market Player Positioning
16.5 Top Winning Strategies
16.6 Competitive Dashboard
16.7 Company Evaluation Quadrant
17 Competitive Landscape
17.1 Amgen Inc
17.1.1 Business Overview
17.1.2 Products Offered
17.1.3 Business Strategies
17.1.4 SWOT Analysis
17.1.5 Major News and Events
17.2 Antares Pharma Inc
17.2.1 Business Overview
17.2.2 Products Offered
17.2.3 Business Strategies
17.2.4 SWOT Analysis
17.2.5 Major News and Events
17.3 Becton Dickinson and Company
17.3.1 Business Overview
17.3.2 Products Offered
17.3.3 Business Strategies
17.3.4 SWOT Analysis
17.3.5 Major News and Events
17.4 Bristol-Myers Squibb Company
17.4.1 Business Overview
17.4.2 Products Offered
17.4.3 Business Strategies
17.4.4 SWOT Analysis
17.4.5 Major News and Events
17.5 Eisai Co. Ltd
17.5.1 Business Overview
17.5.2 Products Offered
17.5.3 Business Strategies
17.5.4 SWOT Analysis
17.5.5 Major News and Events
17.6 Eli Lilly and Company
17.6.1 Business Overview
17.6.2 Products Offered
17.6.3 Business Strategies
17.6.4 SWOT Analysis
17.6.5 Major News and Events
17.7 Haselmeier GmbH (Sulzer Ltd.)
17.7.1 Business Overview
17.7.2 Products Offered
17.7.3 Business Strategies
17.7.4 SWOT Analysis
17.7.5 Major News and Events
17.8 Johnson & Johnson
17.8.1 Business Overview
17.8.2 Products Offered
17.8.3 Business Strategies
17.8.4 SWOT Analysis
17.8.5 Major News and Events
17.9 Mylan N.V. (Viatris Inc.)
17.9.1 Business Overview
17.9.2 Products Offered
17.9.3 Business Strategies
17.9.4 SWOT Analysis
17.9.5 Major News and Events
17.10 Novartis AG
17.10.1 Business Overview
17.10.2 Products Offered
17.10.3 Business Strategies
17.10.4 SWOT Analysis
17.10.5 Major News and Events
17.11 SHL Medical AG
17.11.1 Business Overview
17.11.2 Products Offered
17.11.3 Business Strategies
17.11.4 SWOT Analysis
17.11.5 Major News and Events
17.12 Teva Pharmaceutical Industries Ltd
17.12.1 Business Overview
17.12.2 Products Offered
17.12.3 Business Strategies
17.12.4 SWOT Analysis
17.12.5 Major News and Events
17.13 Ypsomed Holding AG
17.13.1 Business Overview
17.13.2 Products Offered
17.13.3 Business Strategies
17.13.4 SWOT Analysis
17.13.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
18 Strategic Recommendations
19 Appendix